|
1781
|
C 646
|
HAT inhibitor (p300/CBP selective) |
€60.00 |
|
2210
|
C 7280948
|
Sulfone inhibitor of PRMT1 |
€85.00 |
|
2575
|
C-DIM12
|
Nurr1 activator that stimulates apoptosis in bladder cancer cells |
€85.00 |
|
2828
|
C-DIM5
|
Nur77 agonist |
€95.00 |
|
2827
|
C-DIM8
|
Nur77 antagonist |
€95.00 |
|
1819
|
Cabozantinib S-malate
|
Inhibitor of multiple receptor tyrosine kinases, specifically MET and VEGFR2 |
€60.00 |
|
2662
|
CAIX Inhibitor S4
|
Carbonic anhydrase (CA) IX/XII inhibitor |
€90.00 |
|
2170
|
CAL 101
|
PI3K inhibitor (p110 δ specific) |
€95.00 |
|
1818
|
Calhex 231 hydrochloride
|
NAM of the extracellular CaSR |
€99.00 |
|
2803
|
Cambinol
|
Inhibitor of SIRT1 and SIRT2 |
€95.00 |
|
3122
|
Canagliflozin
|
Highly potent and selective SGLT2 inhibitor |
€70.00 |
|
3104
|
Candesartan cilexetil
|
Potent and highly specific AT2 receptor antagonist |
€50.00 |
|
1234
|
Cannabidiol
|
GPR55 antagonist |
€105.00 |
|
3460
|
Capecitabine
|
Oral prodrug of fluorouracil; TYMS inhibitor |
Recently added
|
€50.00 |
|
3423
|
Capmatinib
|
Highly potent, selective, ATP competitive and orally bioavailable c-MET inhibitor |
€80.00 |